During and especially after the COVID-19 pandemic and the extreme government overreach, Americans and citizens all over the world started to question the agencies and organizations put in place to protect the people. What was seen during the pandemic was outlandish mandates and a COVID-19 drug that did little to fight the virus. Still, even today, the Biden administration pushes for more COVID-19 funding for tests, research, and the COVID-19 jab. But while the COVID-19 agenda has been exposed, looking back before the pandemic started shows people like Pfizer CEO Albert Bourla speaking at the World Economic Forum about medications and the ability to place microchips in them.
Taking a look at the video below, Bourla was asked by an audience member at the forum about how technology and medicines can be integrated. Happy to take the question, the CEO admitted that the FDA had approved a drug that came with a digital sensor that could have the capabilities of telling a doctor or agency when the pill had been digested.
MORE NEWS: Two Voices On The Biden Economy
Bourla explained the technology as being “ basically a biological chip that is in the tablet and once you take the tablet it sends a signal that you took the tablet,” Bourla said. “Imagine the implications of that compliance. The insurance companies can know that the medicines that patients should take, they do take them. It is fascinating what happens in this field.”
The exact drug Bourla was discussing was abilify mycite, which was approved by the FDA in 2017 and became the first digital ingestion tracking system. According to the FDA, “The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.”
The organization added, “The system works by sending a message from the pill’s sensor to a wearable patch. The patch transmits the information to a mobile application so that patients can track the ingestion of the medication on their smart phone. Patients can also permit their caregivers and physician to access the information through a web-based portal.”
Again, the video shown above was taken in 2018, two years before the COVID-19 virus took over the world and shut down entire countries in the process. But although the digital tracking system hasn’t been linked to the COVID-19 jab, many critics of the drug and companies like Pfizer are claiming that the pharmaceutical company could be using the technology in the drug.
This piece was written by Zach Heilman on May 20, 2022. It originally appeared in RedVoiceMedia.com and is used by permission.
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of LifeZette.